At a glance
ClinicalIndex Comparison RecordN/ACompleted· 65 enrolled
Drug / intervention
Edwards PASCAL Transcatheter Valve Repair Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
In Brief
A clinical study evaluating Edwards PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation. Completed, enrolled 65 participants across 15 sites.
Detailed Summary
Early feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTricuspid Regurgitation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 2018
Enrollment StartFeb 2019
Primary CompletionMay 2021
Study CompletionMay 2025
TodayJul 2026
First PostedNov 19, 2018
Enrollment StartFeb 5, 2019
Primary CompletionMay 11, 2021
Study CompletionMay 13, 2025
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.6 years ago
Interventions
Edwards PASCAL Transcatheter Valve Repair Systemdevice
Repair of the tricuspid valve through a transcatheter approach